Evidence map›Paper›PMID 42516786›Full record

ArticlePatient preference and adherence2026

Beyond Medication: A Cross-Sectional Study of How Sex Influences Overall Chronic Disease Adherence Behaviour Using the French Generic Adherence for Chronic Diseases Profile (GACID-P).

Mary A De Vera, Marc Soudant, Christine Rotonda, Vicki Cheng, Alexander J Lin, Cyril Tarquinio, Francis Guillemin

Abstract read
In one paragraph

Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mary A De VeraFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0002-2205-2683
Marc SoudantCHRU Nancy, Inserm, University of Lorraine, CIC, Clinical Epidemiology, Nancy, F-54000, France.
Christine RotondaInserm, INSPIIRE, University of Lorraine, Metz, F-57000, France.
Vicki ChengFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Alexander J LinFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0009-0009-5598-336X
Cyril TarquinioInserm, INSPIIRE, University of Lorraine, Metz, F-57000, France.
Francis GuilleminCHRU Nancy, Inserm, University of Lorraine, CIC, Clinical Epidemiology, Nancy, F-54000, France.ORCID 0000-0002-9860-7024

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adherence research has historically focused on medication-taking behaviors. While evidence suggests that males are generally more adherent to medication regimens than females, the influence of sex on overall adherence behaviors remains unclear. We explored how sex influences a multidimensional profile of adherence beyond medication using the Generic French Adherence in Chronic Diseases Profile (GACID-P). Methods: We conducted a cross-sectional study using data from the validation of the GACID-P. Participants were adults (>18 years) with chronic conditions attending specialist care across the Grand-Est region of France. The 25-item self-report GACID-P assesses four domains of adherence - Intention to comply with treatment, Forgetting to take medication, Healthy lifestyle, and Limitation of risk-related consumer habits - with scores ranging from 0 (worst) to 10 (best), except for forgetting, which is reverse scored. Analyses included sex-stratified comparisons, multivariable linear regression models, and multivariate analysis of variance to examine sex-based adherence patterns within and across domains. Results: Among 397 participants (53% male; mean age: males 57.1 ± 10.7, females 59.3 ± 11.7), domain scores indicated generally good adherence. Within domains, males had higher scores than females for Intention to comply (9.18 ± 1.15 vs 8.96 ± 1.51), less Forgetting to take medication (1.35 ± 2.42 vs 1.82 ± 2.85), more Healthy lifestyle (6.92 ± 1.95 vs 6.61 ± 2.00), while females scored higher for Limitation of risk-related consumer habits (6.15 ± 2.14 vs 5.24 ± 2.14); however, none of these differences reached statistical significance. Across domains, a multivariate analysis suggested a sex effect (Wilks' Lambda = 0.84, F(4,73) = 3.58, p=0.010), driven primarily by differences in Forgetting to take medication where males reported less forgetting than females, when adherence patterns are considered jointly across domains (F(1,76) = 10.39, p = 0.0019). Conclusion: Despite the absence of statistically significant sex-based differences within individual GACID-P domains, a multivariate analysis suggested potential differences when adherence behaviors were considered jointly. While these findings should be interpreted cautiously, they support consideration of a sex-based lens to better understand adherence.

Indexed as

adherencehealth measurementsex and gender-based analysissurvey

Identifiers

PMID42516786
PMCPMC13402640

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.